Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer.
Stabile, Laura P
Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 03 2018 - 399-412 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1556-1380
10.1016/j.jtho.2017.11.126 doi
Animals
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Aromatase Inhibitors--pharmacology
Carcinogens
Disease Models, Animal
Female
Humans
Lung Neoplasms--drug therapy
Mice
Nicotiana--adverse effects
Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 03 2018 - 399-412 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1556-1380
10.1016/j.jtho.2017.11.126 doi
Animals
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Aromatase Inhibitors--pharmacology
Carcinogens
Disease Models, Animal
Female
Humans
Lung Neoplasms--drug therapy
Mice
Nicotiana--adverse effects